Revisiting Essure—Toward Safe and Effective Sterilization. Issue 2 (February 2016) - Dhruva, Sanket S.
Abstract : Obstet Gynecol Surv 2016;71(2):86–87 In 2002, a novel nonsurgical birth control implant, the Essure system, was fast tracked for Food and Drug Administration (FDA) approval. At that time, Essure was and has remained the only permanent birth control option for women other than tubal litigation, a major surgical procedure.